SCHEMBL27437788

SCHEMBL27437788

CC(=O)OC(O)c1c(CO)cnc(C)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.47
▸ ALDH1A1 P00352 6/20 0.47
▸ HPGD P15428 4/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ LMNA P02545 5/20 0.47
▸ PDXK O00764 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ AOX1 Q06278 1/20 0.47
▸ TRIM24 O15164 1/20 0.46
▸ TRIM33 Q9UPN9 1/20 0.46
▸ HTT P42858 5/20 0.37
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ APEX1 P27695 1/20 0.37
▸ MPI P34949 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27339626 0.86 PDXK (0.48) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL28806636 0.85 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL27954224 0.83 LMNA (0.43) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL28517132 0.82 KDM4E (0.53) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL27858957 0.81 KDM4E (0.59) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL28031310 0.81 KDM4E (0.40) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL28049059 0.80 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL1545975 0.79 PDXK (0.53) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL29086551 0.79 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL27524467 0.79 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108601777-B Formulations of 2- (4-chlorophenyl) -N- ((2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide 细胞基因公司 2021-08-03 — — CN disclosed
CN-102846599-B Topical composition 日本乐敦制药株式会社 2018-08-10 — — CN disclosed
CN-102920631-B Elastic fibers forming accelerant 乐敦制药株式会社 2017-05-24 — — CN disclosed
CN-106456484-A External preparation 乐敦制药株式会社 2017-02-22 — — CN disclosed
CN-105848632-A Composition for external application to skin 日本乐敦制药株式会社 2016-08-10 — — CN disclosed
CN-105362258-A A tranexamic acid-containing medicinal composition not liable to crystallize WUXI CHENGBO SCIENCE & TECH DEV CO LTD 2016-03-02 — — CN disclosed
CN-104780902-A Composition for external use ROHTO PHARMA 2015-07-15 — — CN disclosed
CN-104220041-A Anti-aging agent containing arctigenin derivative ROHTO PHARMA 2014-12-17 — — CN disclosed
CN-103458865-A External composition ROHTO PHARMA 2013-12-18 — — CN disclosed
CN-103169626-A Stabilizing method for external composition ROHTO PHARMA 2013-06-26 — — CN disclosed
CN-102846599-A External-use composite ROHTO PHARMA 2013-01-02 — — CN disclosed
CN-102793632-A Component for external use ROHTO PHARMA 2012-11-28 — — CN disclosed
CN-102688155-A External composition ROHTO PHARMACEUTICAL C LTD 2012-09-26 — — CN disclosed
CN-102670423-A Elastinase activity inhibitor ROHTO COOPERATION 2012-09-19 — — CN disclosed
CN-101095651-B External composition for skin ROHTO PHARMA 2011-10-12 — — CN disclosed
CN-102188710-A Composition for external use ROHTO PHARMA 2011-09-21 — — CN disclosed
CN-102008729-A Composition for external use ROHTO PHARMA 2011-04-13 — — CN disclosed
CN-101102797-A External composition ROHTO PHARMA (JP) 2008-01-09 — — CN disclosed
CN-101095651-A External composition for skin ROHTO PHARMA (JP) 2008-01-02 — — CN disclosed
CN-1125142-A Target magnetic resonance image-forming contrast medium containing vitamin B6 for liver and gall bladder UNIV WUHAN (CN) 1996-06-26 — — CN disclosed
Send feedback